Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amorfix Life Science (ARFXF)

Amorfix Life Science (ARFXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 44,037
  • Shares Outstanding, K 431,732
  • Annual Sales, $ 10 K
  • Annual Income, $ -9,400 K
  • 60-Month Beta 1.08
  • Price/Sales 2,201.85
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ARFXF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings $-0.01 on 05/13/22
  • Latest Earnings Date 08/11/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0728 +40.11%
on 06/22/22
0.1080 -5.56%
on 06/27/22
+0.0125 (+13.97%)
since 05/27/22
3-Month
0.0700 +45.71%
on 05/12/22
0.1080 -5.56%
on 06/27/22
-0.0009 (-0.87%)
since 03/25/22
52-Week
0.0700 +45.71%
on 05/12/22
0.2150 -52.56%
on 08/09/21
-0.0704 (-40.84%)
since 06/25/21

Most Recent Stories

More News
ProMIS Neurosciences to Commence Trading on Nasdaq Under the Symbol “PMN”

TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 08, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN) (TSX: PMN) (“ProMIS” or the...

ARFXF : 0.1020 (-0.58%)
PMN : 2.0600 (+5.64%)
PMN.TO : 6.00 (-3.85%)
PROMIS ANNOUNCES REVERSE SHARE SPLIT TO MEET NASDAQ LISTING CRITERIA

TORONTO, Ontario and CAMBRIDGE, MA, June 27, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
PROMIS ANNOUNCES REVERSE SHARE SPLIT TO MEET NASDAQ LISTING CRITERIA

TORONTO, Ontario and CAMBRIDGE, MA, June 27, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application

TORONTO, Ontario and CAMBRIDGE, Massachusetts , June 22, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Neurosciences Announces Authorization of Series 1 Preferred Shares

TORONTO, Ontario and CAMBRIDGE, Massachusetts, June 22, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
CORRECTION: ProMIS Neurosciences Announces First Quarter 2022 Results

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) -- There was an error at the end of the first paragraph. March 31, 2021 has...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Holds Annual and Special Meeting of Shareholders All Resolutions Approved

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Neurosciences Announces First Quarter 2022 Results

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 13, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS Neurosciences Reports New Milestones in Potential Therapeutic Approaches for Amyotrophic Lateral Sclerosis (ALS)

TORONTO, Ontario and CAMBRIDGE, MA, April 28, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)
ProMIS appoints experienced industry veteran Larry Altstiel as Chief Medical Officer

Brings decades of experience in Alzheimer’s research at large pharma and biotech...

PMN.TO : 6.00 (-3.85%)
ARFXF : 0.1020 (-0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ProMIS Neurosciences Inc. is a development stage biotechnology company. It focused on discovering and developing medicine therapeutics to treat neurodegenerative diseases in particular Alzheimer's disease and amyotrophic lateral sclerosis. The company's product portfolio includes PMN310, PMN350, PMN330,...

See More

Key Turning Points

3rd Resistance Point 0.1213
2nd Resistance Point 0.1147
1st Resistance Point 0.1083
Last Price 0.1020
1st Support Level 0.0953
2nd Support Level 0.0887
3rd Support Level 0.0823

See More

52-Week High 0.2150
Fibonacci 61.8% 0.1596
Fibonacci 50% 0.1425
Fibonacci 38.2% 0.1254
Last Price 0.1020
52-Week Low 0.0700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar